Allan Graham Watman
Keine laufenden Positionen mehr
Profil
Graham Watman was Executive Chairman of Grant
Thornton (Sydney) and is a non-executive Director
of a number of companies.
Ehemalige bekannte Positionen von Allan Graham Watman
| Unternehmen | Position | Ende |
|---|---|---|
| MANALTO LIMITED | Gründer | 17.12.2007 |
Cryptome Pharmaceuticals Ltd.
 Cryptome Pharmaceuticals Ltd. BiotechnologyHealth Technology Cryptome Pharmaceuticals Ltd is a globally-linked, Melbourne-based biotechnology company created to discover and develop effective and safe protein-derived medicines targeting cancer, cardiovascular disease and chronic inflammatory disorders using a proprietary proteomics-based technology platform. | Direktor/Vorstandsmitglied | 05.04.2006 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Cryptome Pharmaceuticals Ltd.
Cryptome Pharmaceuticals Ltd. BiotechnologyHealth Technology Cryptome Pharmaceuticals Ltd is a globally-linked, Melbourne-based biotechnology company created to discover and develop effective and safe protein-derived medicines targeting cancer, cardiovascular disease and chronic inflammatory disorders using a proprietary proteomics-based technology platform. | Health Technology |
Manalto Ltd.
 Manalto Ltd. Packaged SoftwareTechnology Services Manalto Ltd. engages in the development and commercialization of social media management software. It operates through the following geographical segments: Australia, USA, Ireland, South Africa, and the Netherlands. The company was founded by Gregory Edward Rice, Nick Gatsios, Anthony Owen and Allan Graham Watman on November 2, 2001 and is headquartered in Annangrove, Australia. | Technology Services |
